Bronchoprotective role for endogenous prostaglandin E2.

Journal article

The possibility that impaired production of bronchoprotective factors contributes to the pathogenesis of asthma cannot be excluded. Prostaglandin E2 (PGE2) could be such a factor. It is a dominant cyclo-oxygenase product of airway epithelium and smooth muscle; it has inhibitory effects on inflammatory cells and pathways involved in bronchoconstriction at concentrations known to occur in the airway; inhalation of PGE2 has considerable bronchoprotective effects in patients with asthma; and manoeuvres that increase or decrease endogenous production of PGE2 have beneficial and deleterious effects on airway function.

Authors: Pavord, I; Tattersfield, A

• Journal: Lancet
• Volume: 345
• Issue: 8947
• Pages: 436-438
• Publication date: 1995-02-01
• DOI: 10.1016/s0140-6736(95)90409-3
• EISSN: 1474-547X
• ISSN: 0140-6736
• Language: English
• Keywords: Bronchoconstriction; Humans; Asthma; Dinoprostone